Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice.

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Nonsmall cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality.
• Phytoestrogens, plant-derived compounds with estrogenic activity, have garnered interest for their potential chemopreventive properties.
• Investigating novel therapeutic strategies, including dietary components, is crucial for improving NSCLC outcomes.

Purpose of the Study:

• To evaluate the efficacy of a standardized soy extract (SSE) rich in phytoestrogens on the growth of NSCLC xenografts in vivo.
• To explore the underlying molecular mechanisms, including effects on proliferation, apoptosis, and key signaling pathways.

Main Methods:

• Female athymic mice bearing A549 NSCLC xenografts were treated with varying doses of SSE or a control.
• Tumor growth, proliferation, apoptosis, and the expression of specific proteins (EGFR, p-Akt, p-MAPK) were assessed.
• Estrogen receptor (ER) and serum IGF-1 levels were also analyzed.

Main Results:

• SSE treatment significantly reduced NSCLC xenograft tumor growth, particularly at the higher dose.
• SSE administration led to decreased tumor cell proliferation and increased apoptosis.
• Reduced expression of phosphorylated Akt (p-Akt) was observed in tumors from mice treated with the high dose of SSE.

Conclusions:

• Phytoestrogen-rich SSE demonstrates significant in vivo antitumor activity against NSCLC xenografts.
• Modulation of the Akt-signaling pathway by SSE may contribute to its observed anti-cancer effects.
• These findings support the potential role of dietary phytoestrogens in delaying lung cancer progression.